Companies: 10,795·Total market cap: $144.5T
MBX Biosciences, Inc. Common Stock

MBX Biosciences, Inc. Common Stock

MBXNASDAQHealthcare● Active
$30.28
$-0.63(-2.04%)
Market Cap$1.0B
P/E Ratio
52W High$45.85
52W Low$9.43
Overview

MBX Biosciences, Inc. Common Stock (MBX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · MBX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-2.20mbx eps ttm · mbx earnings per shareEarnings history
PE Ratio (TTM)mbx pe ratio ttm · mbx price to earningsPE Ratio deep dive
Revenue (TTM)0.00mbx revenue ttm · mbx annual revenueFull revenue history
Dividend YieldNo Dividenddoes mbx pay dividends · mbx dividend yieldDividend history
Shares Outstanding36.5Mmbx shares outstanding · mbx floatShares outstanding history
Next EarningsAug 6, 2026Est.mbx earnings date · mbx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
mbx biosciences, inc. common stock revenue · mbx revenue 2025
FY 2025Net Income-$87.0M▼ 40.45% YoY
202320242025
mbx biosciences, inc. common stock net income · mbx profit 2025
FY 2025EPS$-2.38▼ 28.65% YoY
202320242025
mbx eps · mbx biosciences, inc. common stock earnings per share 2025
TTM:Revenue: $0.00Net Income: -$86.6MEPS: $-2.20View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy7 analystsis mbx a buy · mbx analyst rating
Strong Buy
0
Buy
7
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$56.00Low
$30.28Current
$68.80Avg Target127.21% upside
$88.00High
mbx price target · mbx 12 month forecast

Total: 7 · Buy rate: 100.0%

The MBX analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $68.80, representing +127.21% upside from the current price of $30.28.

Stock Performance

Full History
1D-2.04%
1W-0.82%
1M-26.09%
3M-0.88%
YTD-3.99%
1Y+166.55%
5Y+28.03%

About MBX Biosciences, Inc. Common Stock

CEOPeter Kent Hawryluk
IPO DateJan 14, 2000
Employees43
CountryUS
Websitembxbio.com

MBX Biosciences, Inc. Common Stock MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its l…

what is mbx biosciences, inc. common stock · mbx stock overview · mbx biosciences, inc. common stock company profile · who is mbx biosciences, inc. common stock ceo · mbx NASDAQ · mbx biosciences, inc. common stock headquarters · mbx biosciences, inc. common stock business segments

About Stock Overview & Key Data

MBX Biosciences, Inc. Common Stock (MBX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 14, 2000. As of the latest trading session, MBX stock price is $30.28, with a market capitalization of $1.0B. The stock has returned +166.55% over the past 12 months and -3.99% year-to-date.

According to 7 Wall Street analysts, the consensus rating for MBX Biosciences, Inc. Common Stock stock is Buy, with an average 12-month price target of $68.80. In fiscal year 2025, MBX Biosciences, Inc. Common Stock reported revenue of — and net income of -$87.0M. For detailed data — including MBX Biosciences, Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, MBX Biosciences, Inc. Common Stock (MBX) stock price is $30.28. The stock is traded on NASDAQ under the ticker symbol MBX. The 52-week range is $9.43 – $45.85.

MBX stock priceMBX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice